# Mercator Therapeutics, Inc. — Form D

Mercator Therapeutics, Inc. of WELLESLEY, MA, a company, filed a Form D exempt-offering notice with the SEC on 2010-08-09. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2010-08-09
- Form: D
- Accession: 0001496918-10-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.0M
- Amount sold: $2.0M
- Investors: 8
- Date of first sale: 2010-07-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-146121

## Issuer

- Name: Mercator Therapeutics, Inc.
- CIK: 0001496918
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 22 AUBURN ROAD, WELLESLEY, MA, 02481
- Phone: 339-223-0441

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Christopher DT Guiffre | Director | Waltham, MA |
| Mark DT Leuchtenberger | Director | Wellesley, MA |
| Roy R Lobb | Director | Wellesley, MA |
| Christopher DT Guiffre | Executive Officer | Waltham, MA |
| Roy R Lobb | Executive Officer | Wellesley, MA |

## More

- [CIK 1496918 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1496918&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001496918-10-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.